Entrepreneurs

Where have all the people gone that know what they are talking about, especially the apparently arcane subject of network infrastructure? The question is posed by columnist and cocktail party imbiber James Carlini, who challenges policy makers and others to take the network competency test...

The legacy of UW Chancellor John Wiley is not confined to the UW-Madison campus, but throughout the state of Wisconsin, according to columnist Tom Still. In this edition of Inside Wisconsin, Still notes that Wisconsin businesses and campuses throughout the state, particularly UW-Milwaukee, have had...

Is “Return of the Dotcom Bust” coming to a business theater near you? Columnist Brad Spirrison thinks the $15 billion valuation for Facebook could be a prelude to a second "dot-comedy," and he quotes several venture capitalists that view this level of valuation as an...

Unless you regularly are involved in venture capital transactions and stay up to date on recent trends and deal structures, it's hard to know if you're taking advantage of best industry practices. Attorney and columnist Matt Storms has a handy resource, the American Bar Association's...

Is there a control mechanism that allows computer programmers into production while still providing some assurance that they are not accidentally jeopardizing (or intentionally manipulating) software? You bet there is, and Jerry Norton explains it in this edition of Boardroom Perspectives. According to Norton, the...

Legislation known as the Cable Competition Bill now has passed both houses of the Wisconsin Legislature and is on its way to Gov. Jim Doyle's desk. The bill would end existing deals between local governments and cable companies, and establish a statewide franchise for service...

Third Wave Technologies, a Madison-based research molecular diagnostics company, has received a $25 million line of credit from Deerfield Management. The additional capital will support the execution of long-range plans for the human papilloma virus and the hospital lab markets. ...

The high cost of developing prescription drugs has started a race to make pharmaceutical products more affordable, and venture capitalists are placing bets on the outcome. CDI Bioscience, a Madison-based company that has developed a technology to boost protein production and lower drug-manufacturing costs, will...

New distribution agreements signed by TomoTherapy will extend access to the company's cancer treatment technology to a greater percentage of the global marketplace. TomoTherapy has signed contracts with distributors in Israel, Greece, Poland, Turkey, Russia, and the United Arab Emirates. ...